Rajula, Hema Sekhar Reddy
Manchia, Mirko
Agarwal, Kratika
Akingbuwa, Wonuola A.
Allegrini, Andrea G.
Diemer, Elizabeth
Doering, Sabrina
Haan, Elis
Jami, Eshim S.
Karhunen, Ville
Leone, Marica
Schellhas, Laura
Thompson, Ashley
van den Berg, Stéphanie M.
Bergen, Sarah E.
Kuja-Halkola, Ralf
Hammerschlag, Anke R.
Järvelin, Marjo Riitta
Leval, Amy
Lichtenstein, Paul
Lundstrom, Sebastian
Mauri, Matteo
Munafò, Marcus R.
Myers, David
Plomin, Robert
Rimfeld, Kaili
Tiemeier, Henning
Ystrom, Eivind
Fanos, Vassilios
Bartels, Meike
Middeldorp, Christel M. http://orcid.org/0000-0002-6218-0428
Funding for this research was provided by:
H2020 Marie Skłodowska-Curie Actions (721567)
Article History
Received: 27 September 2019
Accepted: 21 December 2020
First Online: 20 January 2021
Compliance with ethical standards
:
: The author(s) have no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
: The UK Medical Research Council and Wellcome (Grant ref: 102215/2/13/2) and the University of Bristol provide core support for ALSPAC. A comprehensive list of grants funding is available on the ALSPAC website. (ExternalRef removed).GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe.
: CATSS was supported by the Swedish Council for Working Life, funds under the ALF agreement, the Söderström Königska Foundation and the Swedish Research Council (Medicine, Humanities and Social Science, and SIMSAM).
: The generation and management of GWAS genotype data for the Generation R Study was done at the Genetic Laboratory of the Department of Internal Medicine, Erasmus MC, the Netherlands. We thank Pascal Arp, Mila Jhamai, Marijn Verkerk, Lizbeth Herrera and Marjolein Peters for their help in creating, managing and QC of the GWAS database. The general design of Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, the Netherlands Organization for Health Research and Development (ZonMw), the Netherlands Organisation for Scientific Research (NWO), the Ministry of Health, Welfare and Sport and the Ministry of Youth and Families. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreements No 633595 (DynaHEALTH) and 733206 (LIFECYCLE).
: MOBA are supported by the Norwegian Ministry of Health and Care Services and the Ministry of Education and Research, NIH/NIEHS (contract noN01-ES-75558), NIH/NINDS (Grant No.1 UO1 NS 047537-01 and Grant No.2 UO1 NS 047537-06A1). Genotyping and data access was funded by the the Research Council of Norway grant agreements 229624 “HARVEST”, 223273 “NORMENT”, and 262177 “Intergenerational Transmission of Internalizing and Externalizing Psychopathological Spectra”.
: Data collection in the NTR was supported by NWO: Twin-family database for behavior genetics and genomics studies (480-04-004); “Spinozapremie” (NWO/SPI 56-464-14192; “Genetic and Family influences on Adolescent psychopathology and Wellness” (NWO 463-06-001); “A twin-sib study of adolescent wellness” (NWO-VENI 451-04-034); ZonMW “Genetic influences on stability and change in psychopathology from childhood to young adulthood” (912-10-020); “Netherlands Twin Registry Repository” (480-15-001/674); “Biobanking and Biomolecular Resources Research Infrastructure” (BBMRI-NL (184.021.007). We acknowledge FP7-HEALTH-F4-2007, grant agreement no. 201413 (ENGAGE), and the FP7/2007–2013 funded ACTION (grant agreement no. 602768) and the European Research Council (ERC-230374). Part of the genotyping was funded by the Genetic Association Information Network (GAIN) of the Foundation for the National Institutes of Health, Rutgers University Cell and DNA Repository (NIMH U24 MH068457-06), the Avera Institute, Sioux Falls, South Dakota (USA) and the National Institutes of Health (NIH R01 HD042157-01A1, MH081802, Grand Opportunity grants 1RC2 MH089951 and 1RC2 MH089995).
: NFBCC1986 study has received financial support from EU QLG1-CT-2000-01643 (EUROBLCS) Grant no. E51560, NorFA Grant no. 731, 20056, 30167, USA/NIHH 2000 G DF682 Grant no. 50945, NIHM/MH063706, H2020-633595 DynaHEALTH action and Academy of Finland EGEA-project (285547).
: Supported by The Swedish Council for Working Life and the Swedish Research Council.
: TEDS is supported by a program grant to RP from the UK Medical Research Council (MR/M021475/1), with additional support from the US National Institutes of Health (AG046938). The research leading to these results has also received funding from the European Research Council under the European Union’s Seventh Framework Programme (FP7/2007–2013)/grant agreement no. 602768. RP is supported by a Medical Research Council Professorship award (G19/2).